4-((4-Chloro-3-nitrobenzylidene)amino)-3-(m-tolyl)-1H-1,2,4-triazole-5(4H)-thione

Catalog No. :
ACLXUA969
CAS No. :
478256-23-4
Molecular Formula :
C16H12ClN5O2S
Molecular Weight :
373.83

IUPAC Name:(E)-4-((4-chloro-3-nitrobenzylidene)amino)-5-(m-tolyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

4-((4-Chloro-3-nitrobenzylidene)amino)-3-(m-tolyl)-1H-1,2,4-triazole-5(4H)-thione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((4-Chloro-3-nitrobenzylidene)amino)-3-(m-tolyl)-1H-1,2,4-triazole-5(4H)-thione
IUPAC Name(E)-4-((4-chloro-3-nitrobenzylidene)amino)-5-(m-tolyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
MDL No.MFCD03675690
Molecular FormulaC16H12ClN5O2S
Molecular Weight373.83
SMILESS=C1NN=C(C2=CC=CC(C)=C2)N1/N=C/C3=CC=C(Cl)C([N+]([O-])=O)=C3
InChI KeyWKMXFBXEHOVTBP-GIJQJNRQSA-N
SynonymSALOR-INT L231010-1EA;4-((4-CL-3-NITROBENZYLIDENE)AMINO)-5-(3-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL;3H-1,2,4-Triazole-3-thione, 4-[[(4-chloro-3-nitrophenyl)methylene]amino]-2,4-dihydro-5-(3-methylphenyl)-
CAS No.478256-23-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLXUA969 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNPSI759 route compound structure diagram
    ACNPSI75916588-34-4 In Stock
  4. Then
  5. ACLXUA969 route product structure diagram
    ACLXUA969478256-23-4
Inquiry

2. ACLXUA969 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLXUA969 route product structure diagram
    ACLXUA969478256-23-4
Inquiry

Comments (0)